Additional Investigations Clause Samples

The "Additional Investigations" clause allows one or both parties to conduct further inquiries or due diligence beyond the initial scope agreed upon in the contract. This may include activities such as site inspections, reviewing additional documents, or consulting with experts to verify information relevant to the agreement. By providing a formal mechanism for extra investigation, the clause helps ensure that all parties have access to the information they need to make informed decisions and reduces the risk of misunderstandings or undisclosed issues.
Additional Investigations. If the IRO identifies any transactions that were not supported by source documentation and/or were not appropriately included in, or excluded from, the calculation of AMP in accordance with King’s policies, procedures, and methodology, such transactions shall be considered an error. The IRO shall conduct such Additional Investigation as may be necessary to determine the root cause of the error. For example, the IRO may need to review additional Appendix B King Pharmaceuticals CIA documentation, conduct additional interviews with appropriate personnel, and/or review additional contracts to identify the root cause of the error. Upon completion of this review and Additional Investigation, if warranted, the IRO will report to the OIG its findings relating to any errors and their root cause(s). In the event the IRO finds more than one error for the quarter under review, the IRO will perform a second set of review procedures relating to the AMP calculations for the same quarter and population of data as in the first review. These additional review procedures will be developed in consultation with the OIG after King has submitted its management response to the IRO findings to the OIG, after the OIG has reviewed and considered King’s management response, and the OIG has determined that additional testing is warranted.
Additional Investigations. Information provided and/or requested under this section represents investigations that will be necessary for the Cogenerator to determine the capacity of the existing Compressor Station and to provide the City input on the Compressor Station’s capability to supply the NCEP Fuel Requirement and the Cogeneration Facilities' Fuel Requirement at NCCF, along with any potential reliability issues.
Additional Investigations. The Concessionaire shall evaluate all existing data of previous investigations for the construction of the new quay and the landside utilities and shall, if necessary, carry out all new investigations, if it considers that available information is not sufficient.
Additional Investigations. The City reserves the right to make such additional investigations as it deems necessary to establish the competence and financial stability of any offeror submitting a proposal.
Additional Investigations. Region 4 ESC reserves the right to make such additional investigations as it deems necessary to establish the capability of any Offeror. We understand and agree to this provision.
Additional Investigations. City may conduct additional investigations needed to determine the competence or financial stability of any Offeror.
Additional Investigations a. GSA conducted a GPR survey of the area agreed upon by GSA and DCSHPO (Exhibit 25), which encompasses Area N and other noncontiguous areas, which have the potential to be National Register-eligible. Additional archaeological resources were discovered during the GPR survey, and GSA consulted with the DCSHPO on measures to avoid, minimize or mitigate adverse effects to the resources. GSA has documented the GPR findings in the appendix E of the ARMP and in Management Summary: St. Elizabeths West Campus GPR Survey Archaeological Investigations by ▇▇▇▇▇▇ (2015) and Preliminary Management Summary: St. Elizabeths West Campus Center Building Foundation Repair Archaeological Investigations by ▇▇▇▇▇▇ (2015). b. Per the Management Summary: St. Elizabeths West Campus GPR Survey Archaeological Investigations by ▇▇▇▇▇▇ (2015) and Preliminary Management Summary: St. Elizabeths West Campus Center Building Foundation Repair Archaeological Investigations by ▇▇▇▇▇▇ (2015), GSA has identified potentially National Register-eligible archaeological resources in 51SE046 Area F, 51SE046 adjacent to the north façade of Building 3 (West Wing), 51SE046 adjacent to the north façade of Building 1 (Center Building), 51SE046 adjacent to the east façade of Building 4 (East Wing), as well as 51SE046 Area N.
Additional Investigations. During the Lessee’s pre-survey meeting with the Lessor (see Addendum “C”, 2.1.2), the Lessee must present to the Lessor any proposed additional or alternate instrumentation and methods other than those described above, such as underwater imaging, diver investigation, remotely operated vehicles, coring, and additional survey lines.
Additional Investigations. If the IRO identifies any prices reviewed in Part One or Part Two of the Reported Prices Procedures for BP that were not accurately reflected in King’s systems and/or were not appropriately included in, or excluded from, King’s BP determination in accordance with King’s policies, procedures, and methodologies, such prices shall be considered an error. The IRO shall conduct such Additional Investigation as may be necessary to determine the root cause of the error. For example, the IRO may need to review additional documentation, conduct additional interviews with appropriate personnel, and/or review additional contracts to identify the root cause of the error. Upon completion of this review and Additional Investigation, if warranted, the IRO will report to the OIG its findings relating to any errors and their root cause(s). In the event the IRO finds more than one error for the quarter under review in Part One or Part Two testing, the IRO will perform a second set of Part One or Part Two testing procedures (i.e., Part One or Part Two testing depending which Part of the Reported Prices Procedures for BP resulted in an Additional Investigation being warranted) for the same quarter and population of data after King has submitted its management response to the IRO findings to the OIG, after the OIG has reviewed and considered King’s management response, and the OIG has determined that additional Part One or Part Two testing is warranted following consultations with King and the IRO. Should it be determined that additional Part One or Part Two testing is warranted, the IRO shall: a) If additional Part One testing is required, test a random selection of an additional five King Customers and contract Appendix B King Pharmaceuticals CIA prices associated with those Customers from the large King Customer pool; and/or b) If additional Part Two testing is required, test the next five Medicaid rebate eligible NDCs with the highest amounts of Medicaid rebates (total dollars) paid by King.